| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 7.005 | 82.443 | 81.237 | 80.627 | 82.376 | 86.383 | 87.836 | - |
| Total Income - EUR | - | - | 7.005 | 82.677 | 81.653 | 81.069 | 82.493 | 87.157 | 89.640 | - |
| Total Expenses - EUR | - | - | 89 | 4.582 | 8.087 | 6.591 | 8.822 | 11.550 | 10.732 | - |
| Gross Profit/Loss - EUR | - | - | 6.916 | 78.095 | 73.566 | 74.477 | 73.670 | 75.606 | 78.908 | - |
| Net Profit/Loss - EUR | - | - | 6.706 | 75.620 | 71.116 | 72.047 | 71.443 | 73.384 | 66.735 | - |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Embriogen Dh S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 900 | 518 | 1.382 | 780 | 356 | 1.096 | - |
| Current Assets | - | - | 7.050 | 82.015 | 71.711 | 72.679 | 72.381 | 75.561 | 73.186 | - |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 61 | - |
| Receivables | - | - | 7.005 | 6.877 | 6.973 | 7.517 | 21.607 | 14.988 | 21.834 | - |
| Cash | - | - | 45 | 75.139 | 64.738 | 65.162 | 50.774 | 60.573 | 799 | - |
| Shareholders Funds | - | - | 6.750 | 82.245 | 71.558 | 72.992 | 72.670 | 75.307 | 69.035 | - |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | - | - | 301 | 670 | 671 | 1.069 | 720 | 610 | 5.693 | - |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Embriogen Dh S.r.l.